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and Signs Pain Scale (S-LANSS); and, 3. factors associated with
NP symptoms as measured by the mPD-Q.
Methods: Eligible participants were members of an established
population-based OA cohort with chronic symptomatic knee OA.
A standardized questionnaire was mailed to 426 cohort members
to assess NP symptoms (mPD-Q, S-LANSS); osteoarthritis status
(WOMAC, Von Korff Chronic Pain Grade); psychological factors
including depression (Center for Epidemiological Studies Depres-
sion Scale), anxiety (Hospital Anxiety and Depression scale) pain
catastrophizing (Pain Catastrophizing Scale), and sleepiness (Ep-
worth Daytime Sleepiness scale); co-morbid medical conditions;
possible confounding neurological conditions; and medication use.
The cut-point score (≥19) identiﬁed in other chronic pain popu-
lations was used to identify NP symptoms (‘NP range’ scores) in
this study. The proportion of knee OA participants with mPD-Q
scores in the NP range was calculated using a 95% conﬁdence
interval (CI). Spearman’s correlation between continuous mPD-Q
and S-LANSS scores was examined. Potential correlates of NP
symptoms were ﬁrst assessed using bivariate analysis, followed
by logistic regression modeling.
Results: Out of 426 cohort members who were sent a study
questionnaire, 259 were deemed eligible to participate. The re-
sponse rate among eligible cohort members was 66% (171/259).
The proportion (95% CI) of participants with mPD-Q scores in
the NP range was 0.28 (0.21-0.35). After removal of participants
with neurological conditions, 0.19 (0.12-0.29) still had scores in
the NP range. Continuous mPD-Q scores were highly correlated
with continuous S-LANSS scores. NP range scores were strongly
associated with OA severity, depressive and anxious symptoms,
pain catastrophizing, and a higher frequency of neurological con-
ditions, and chronic back or hip pain with radiation down either
leg (‘pain radiation’). On multivariable analysis, pain intensity, ‘pain
radiation’, and neurological conditions were independently related
to NP range scores.
Conclusions: A substantial proportion of older adults with chronic
symptomatic knee OA had symptoms of NP on the mPD-Q sug-
gesting neuropathic mechanisms may be contributing to their pain
experience. This subgroup of people may beneﬁt from further
evaluation for NP and consideration of NP medications. Validation
work is ongoing on the mPD-Q, which may serve as a clinically
feasible tool to aid the identiﬁcation of NP in people with OA.
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Purpose: Selective activation of peripheral receptors has the im-
portant advantage of providing effective analgesia without side
effects typically associated with centrally acting drugs. Several
data suggest that both opioid and NMDA receptors are local-
ized at peripheral level, and drugs acting on these receptors may
produce antinociception after topical administration, however, the
antinociceptive effect of endogenous ligands at these receptors is
poorly clariﬁed. It is also well known that the organism can express
very effective antinociception in different circumstances by releas-
ing of various endogenous ligands. The goal of this study was to
determine the antinociceptive potency of the endogenous opioid
peptide, endomorphin-1, and the endogenous NMDA receptor an-
tagonist, kynurenic acid and their interaction at peripheral level in
the rat inﬂamed joint model.
Methods: Mechanical hypersensitivity was produced by injection
of carrageenan (300μg/20μl) into the tibiotarsal joint of the right
hind leg. The mechanical pain threshold, the withdrawal from me-
chanical stimulation to the plantar aspect of the hindpaws, was
assessed by logarithmic series of calibrated von Frey monoﬁl-
aments (0.064-110 g). Endomorphin-1 (30, 100 and 200 μg),
kynurenic acid (30, 100, 200 and 400 μg) and their combinations
in a ﬁxed-dose ratio: (1:1) were given into the inﬂamed joint 3
hours after the induction of inﬂammation, and the pain threshold
was determined repeatedly for 75 min after the drug administra-
tions. To determine the changes in the size of the inﬂamed joint,
the cross section area of ankle joint was also calculated.
Results: None of the treatments inﬂuenced the degree of edema.
Neither endomorphin-1 nor kynurenic acid administered to the
inﬂamed joint inﬂuenced the pain threshold at the non-inﬂamed
side. Both ligands produced dose-dependent anti-hyperalgesia,
and the highest doses caused prolonged effect. Endomorphin-
1 had higher potency (ED50 value was 112 μg [CI: 80-146])
compared to kynurenic acid (ED50 value was 204 μg [CI: 160-
251]). The coadministration of endomorphin-1 with kynurenic acid
caused potentiated and/or prolonged antinociceptive effect. The
ED50 value of the combination was 141 μg [CI: 83-182], which did
not differ signiﬁcantly from the theoretically additive value (ED50
145 μg [CI: 68-237]), thus the interaction between these ligands is
additive. None of the treatments caused any sign of side-effects.
Conclusions: This study has shown that the intra-articularly ad-
ministered endogenous μ-opioid receptor agonist EM1 and the
NMDA receptor antagonist KYNA dose-dependently decreased
the mechanical allodynia without signs of systemic side effects.
The coadministration of these ligands produced additive interac-
tion, thus a decreased dose of each drug can lead to effective
antinociception. Furthermore, we did not ﬁnd any changes on the
normal side. Therefore, we may exclude systemic antinocicep-
tive effects of these ligands. These results suggest an important
direction for the development of pain strategies that focus on
the coadministration of different endogenous ligands at peripheral
level.
This work was supported by a grant of the National Research
and Development Ofﬁce, Hungary (OMFB-0066/2005/DNT) and
the Hungarian Research Grant (OTKA, K60278).
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Purpose: To evaluate the construct validation of behavioural and
physiologic tools to measure orthopaedic pain induced in an ex-
perimental canine osteoarthritis (OA) model. We hypothesized
that these methods will present different validity and reliability be-
tween placebo-controlled and anti-resorptive (tiludronate)-treated
dogs. This drug was chosen for its potential as pain-killer without
sedative activity.
Methods: This prospective randomized blinded study was per-
formed on healthy adult dogs divided into two groups: Group 1,
eight control dogs, and Group 2, eight tiludronate-treated dogs,
2 mg/kg, subcutaneous. Under standardized procedures, transec-
tion of the right anterior cruciate ligament was carried out at Day
(D) 0. Treatments were repeated every two weeks from D0 to D56.
Two observers, blinded to treatment, assessed pain using the
visual analog scale (VAS) and multiparametric pain scale (Stan-
dardized Technician Arthritis Pain Scale [STAPS]/Observer 1 and
Standardized Veterinarian Arthritis Pain Scale [SVAPS]/Observer
2). Objective methods comprised podobarometric gait analysis
to record peak vertical force (PVF), locomotor activity record-
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ing, quantiﬁcation of behavioural change using automated video-
analysis, and electrodermal activity (EDA) used as an indirect
quantiﬁcation of pain. Evaluations were performed at baseline,
D28, and D56. General linear model for repeated measures was
performed for the analysis of rating scores, PVF, locomotor activity
and EDA. Logistic regression for repeated measurements was
applied to ordinal and video-analysis data.
Results: VAS scores increased from D0 to D28 and remained
stable from D28 to D56 for both observers. The overall scores
of STAPS and SVAPS increased over time but no difference
between groups was observed. The component “Willingness to
hold up contra-lateral limb” in SVAPS was lower (p=0.0495), and
PVF higher (p=0.05), in Group 2 compared to Group 1 at D56.
The criteria “Lameness when walking”, “Lameness when trotting”,
and “Reaction to palpation” increased over time in both groups
(p<0.01). Intra-observer reliability was good to excellent for Ob-
server 1 (rho = 0.86-0.73) and Observer 2 (rho = 0.91-0.72) over
time. Locomotor activity was higher for Group 2 when compared
with Group 1 from D0 to D28 (p<0.03), and the difference re-
mained up to D56 without reaching statistical signiﬁcance. On
video-analysis, the occurrence of “Standing with full weight bear-
ing” was 7.7 times more present in Group 2 as compared to Group
1 at D56 (p=0.03). The occurrence of “Walking/Trotting with no
lameness” was respectively 5.5 and 6.5 times higher in Group 2
as compared to Group 1 at D56 (p<0.01). The EDA had a trend to
be lower in Group 2 when compared to Group 1 at D24 (P=0.059),
and without statistical signiﬁcance at D56.
Conclusions: Behavioural methods of pain assessment in dogs
indicated different levels of activity and discomfort in relation
to treatment (tiludronate or placebo). Despite idiosyncratic com-
portment, similar conclusions can be drawn on behaviour video-
analysis and locomotor activity. Lameness and orthopaedic ma-
nipulation were indicators of discomfort on rating pain scales.
Tiludronate improved one component of SVAPS without affect-
ing the dog attitude (no sedative effect). Objective methods were
more sensitive and speciﬁc to detect the functional outcomes on
tiludronate-treated dogs.
040
INJECTION OF ALLOGENEIC IMMUNOSELECTED STRO-3+
MESENCHYMAL PRECURSOR STEM CELLS INTO LUMBAR
INTERVERTEBRAL DISCS ATTENUATES DEGENERATION
AND PROMOTES THE RESTORATION OF THE DISC
EXTRACELLULAR MATRIX. AN EXPERIMENTAL STUDY IN
AN OVINE MODEL OF DISC DEGENERATION
P. Ghosh1, S. Itescu1, R. Moore2, B. Vernon-Roberts2,
T. Goldschlager3, A. Zannettino2, S. Gronthos2, C. Little4,
C. Shu4, J. Melrose4
1Mesoblast Ltd, Melbourne, Australia; 2Inst. of Vet. and Med. Sci.,
Adelaide, Australia; 3Monash Univ., Melbourne, Australia; 4Univ.
of Sydney, Sydney, Australia
Purpose: Disc degeneration is a major cause of morbidity world-
wide but non-surgical treatments are presently inadequate. In this
study we examined the potential of allogeneic immunoselected
STRO-3+ mesenchymal precursor stem cells (MPC), administered
intra-discally (ID), to restore matrix integrity in an ovine model of
disc degeneration.
Methods: Three adjacent lumbar discs (L3-L4, L4-L5, and L5-
L6) of thirty-six age-matched adult male wethers were injected
ID with 1.0 IU Chondroitinase ABC (cABC) to depolymerise their
proteoglycans (PGs) and initiate disc degeneration. The remain-
ing lumbar discs (L1-L2 and L2-L3) were non-injected and were
used as normal controls. Fifteen weeks (± 3 weeks) after cABC
injection, L3-L4 discs were injected with Hyaluronan (HA) mixed
with either a high dose (HD-MPC) (4 million)(N=6) or low dose
(LD-MPC) (0.5 million)(N=6) cells. L4-L5 discs were untreated
(cABC alone)(N=6) and L5-L6 discs were injected with HA alone
(cABC+HA)(N=6). Animals were necropsied at 3 months (N=6)
or 6 months (N=6) after treatments. Radiographs and MRIs were
taken prior to cABC (Baseline), after cABC injection and imme-
diately prior to treatments, and at necropsy. Serial sagittal MRI
slices of the whole discs were assessed by a blinded observer to
grade disc degeneration using an ovine disc MRI scoring system.
From the radiographs the disc height index (DHI) scores were
calculated using a published method. At necropsy disc tissues,
together with a segment of the vertebral bodies, were removed,
processed and stained with Alcian Blue and H&E. Sections were
scored by a blinded observer for degenerative changes using a
published scoring system. Aliquots of the dried ﬁxed disc tissues
were analysed biochemically for PG glycosaminoglycans (GAGs)
and hydroxy proline for collagen content.
Results: Fifteen weeks (± 3 weeks) after injection of cABC,
DHI decreased by ca 50%, conﬁrming a substantial loss of disc
PGs. The DHI results were conﬁrmed by MRI degeneration scores.
There was minimal change in DHI during the subsequent 3 months
post treatments. However by 6 months all treatments showed an
increase in DHI but signiﬁcance was only observed for the low
dose MPC injected discs (p<0.02, ANOVA). Histopathological
scores 3 months post treatments showed that discs injected with
HD-MPC were signiﬁcantly improved (p<0.01) but this difference
was lost by 6 months. In contrast, the 6 months LD-MPC injected
disc histopathology scores were statistically different from the
cABC alone and cABC+HA injected discs (p<0.01) but not from
the non-injected normal control discs (L2-L3). This pattern of tem-
poral response to the different treatments was consistent with the
MRI aggregate disc degeneration scores at 6 months for LD-MPC
injected discs conﬁrming that the low dose MPC effect was more
sustained than for the high dose MPC. Biochemical analysis re-
vealed that the GAG content of the nucleus pulposus of the cABC
and cABC+HA injected discs at 6 months were signiﬁcantly differ-
ent to controls (p<0.05) but the LD-MPC injected discs were not.
Conclusions: Collectively these data support the conclusion that
injection of half a million MPC into degenerate discs accelerated
the reconstitution of a new extracellular matrix and improved disc
height.
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Purpose: High tibial osteotomy (HTO) has established as an
effective method for treatment of unicondylar knee osteoarthritis
(kneeOA). The operation often includes an arthroscopic knee
evaluation for an exact grading of kneeOA and arthroscopy for
treatment of intraarticular pathologies (meniscectomy, extraction
of loose bodies, synovectomy and others).
The impact of cartilage treatments (debridement, bone marrow
stimulation, cartilage transplantation) is still under controversial
discussion.
This arthroscopic study was aimed to evaluate the effect of differ-
ent kinds of treatment (simple joint lavage, mechanical shaving,
thermochondroplasty, microfracturing) in combination with an HTO.
Methods: A total of 228 patients (118 male, 110 female; age 47.8
[36 to 67] years) had undergone implant removal (Angle-stable
HTO [high tibial osteotomy]-plate, Königsee Implantate Germany)
and simultaneous control arthroscopy after medial opening wedge
HTO.
